Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.20.2
Stockholders’ Equity (Tables)
 3 Months Ended
Oct. 31, 2020
Stockholders' Equity Note [Abstract]  
Schedule of stock option activity
    Three months ended
October 31,		  
    2020     2019  
Stock options   $ 166       218  
Restricted stock     1       1  
    $ 167       219  
Schedule of share-based payment arrangement
    Three months ended
October 31,		  
    2020     2019  
Selling, general and administrative   $ 154       219  
Cost of revenues     13       —  
    $ 167       219  
Schedule of stock option activity
    Options     Weighted
Average
Exercise
Price		     Weighted
Average
Remaining
Contractual
Term		     Aggregate
Intrinsic
Value (000s)		  
Outstanding at July 31, 2020       2,636,496     $ 4.05                  
Awarded     68,500     $ 2.14                  
Exercised     —                     $    
Cancelled or expired     (52,000 )   $ 4.51                  
Outstanding at end of period     2,652,996     $ 3.86       2.75 years     $ 23  
Exercisable at end of period     1,537,662     $              1.4 years     $             
Schedule of nonvested performance-based units activity
Grant Date   Total Grant     Forfeitures     Outstanding    

Fair Market Value

At Grant Date (000s)

  
7/31/2018     32,000       (6,000 )     26,000     $ 124  
1/3/2019     80,500       (14,500 )     66,000     $ 196  
2/25/2020     98,600       —       98,600     $ 217